Drug Co. Valeant To Snap Up PharmaSwiss For $484M
Canadian drugmaker Valeant Pharmaceuticals International Inc. said Tuesday it would buy privately held Swiss generics and supplement manufacturer PharmaSwiss SA for $484 million, aiming to expand its presence in Central and...To view the full article, register now.
Already a subscriber? Click here to view full article